Cold-Pressed Palm Oil (Elaeis guineensis)
Cold-pressed palm oil (Elaeis guineensis) is rich in oil palm phenolics (OPP) and tocotrienols, bioactives that reduce oxidative stress by upregulating antioxidant enzymes and modulating vascular tone. Its primary mechanisms include inhibition of lipid peroxidation, preservation of glutathione peroxidase activity, and angiotensin-converting enzyme (ACE) inhibition contributing to blood pressure reduction.

Origin & History
Cold-pressed palm oil is extracted from the mesocarp of the oil palm tree (Elaeis guineensis), native to West Africa and now widely cultivated in Southeast Asia. It is mechanically extracted without heat or chemicals, preserving heat-sensitive compounds compared to refined methods, and consists primarily of saturated (palmitic acid ~50%) and unsaturated fatty acids with minor phenolic compounds.
Historical & Cultural Context
No evidence of historical use in traditional medicine systems was identified in the research. Palm oil is primarily a modern dietary and industrial oil originating from West Africa, with recent nutraceutical interest focused on phenolic compounds extracted from oil palm fruit by-products.
Health Benefits
• Blood pressure reduction: 250 mg/day of oil palm phenolics (OPP) significantly reduced systolic and diastolic blood pressure in healthy adults (RCT, n=97, moderate evidence) • Enhanced antioxidant capacity: 1500 mg/day OPP improved total antioxidant capacity and preserved glutathione peroxidase levels (RCT, n=97, moderate evidence) • Potential lipid profile improvement: Phase II trial showed improvements in hyperlipidemic adults, though specific outcomes not detailed (RCT, n=50, preliminary evidence) • Oxidative stress reduction: OPP enhances antioxidant enzymes including SOD, GSH-Px, and GR (human trial evidence) • Note: Meta-analysis found palm oil consumption increases LDL cholesterol compared to low-saturated fat vegetable oils (strong evidence)
How It Works
Oil palm phenolics (OPP) — including hydroxycinnamic acids and flavonoids — scavenge reactive oxygen species (ROS) and upregulate endogenous antioxidant enzymes such as glutathione peroxidase (GPx) and superoxide dismutase (SOD). Tocotrienols, particularly the delta and gamma isoforms abundant in palm oil, inhibit HMG-CoA reductase and suppress NF-κB-mediated inflammatory signaling. OPP also appears to inhibit angiotensin-converting enzyme (ACE) activity, reducing vasoconstriction and contributing to clinically observed reductions in systolic and diastolic blood pressure.
Scientific Research
Clinical evidence primarily comes from trials testing oil palm phenolics (OPP) extracted from palm oil by-products, including a phase I RCT (PMID: 41188255, n=97) showing blood pressure and antioxidant benefits at 250-1500 mg/day doses. A phase II trial (NCT04573218, n=50) tested 250 mg/day OPP in hyperlipidemic adults, while a 2020 meta-analysis found palm oil consumption increases LDL cholesterol compared to other vegetable oils.
Clinical Summary
A randomized controlled trial (n=97) demonstrated that 250 mg/day of OPP significantly reduced both systolic and diastolic blood pressure in healthy adults, representing moderate-quality evidence. A separate intervention using 1500 mg/day OPP improved total antioxidant capacity and preserved glutathione peroxidase levels compared to placebo. Most existing trials are short-duration and conducted in relatively healthy populations, limiting generalizability to individuals with chronic disease. Overall, evidence is promising but preliminary, with larger and longer-term RCTs needed to confirm cardiovascular and antioxidant endpoints.
Nutritional Profile
Cold-pressed palm oil is composed of approximately 50% saturated fatty acids, 40% monounsaturated fatty acids, and 10% polyunsaturated fatty acids per 100g. Saturated fat is dominated by palmitic acid (C16:0) at ~44g/100g and stearic acid (C18:0) at ~5g/100g. Monounsaturated fat is primarily oleic acid (C18:1) at ~39g/100g. Polyunsaturated fat is mainly linoleic acid (C18:2) at ~10g/100g. Total fat content is ~100g/100g with negligible protein, carbohydrates, and fiber. Key micronutrients include vitamin E as tocotrienols and tocopherols at ~80mg/100g total, with alpha-tocotrienol (~22mg/100g), gamma-tocotrienol (~32mg/100g), and delta-tocotrienol (~7mg/100g) being notable — tocotrienols are up to 60x more potent antioxidants than alpha-tocopherol due to their unsaturated phytyl tail enhancing membrane mobility and bioavailability. Beta-carotene (provitamin A) is present at ~500-700 mcg/100g in unrefined red palm oil, making it one of the richest plant sources. Ubiquinone (CoQ10) is present at ~10-80mg/100g depending on processing. Oil palm phenolics (OPP) including hydroxycinnamic acids, hydroxybenzoic acids, and flavonoids are present primarily in palm vegetation liquor rather than the refined oil itself; cold-pressed variants retain higher OPP concentrations (~100-250mg/100g as gallic acid equivalents). Squalene is present at ~0.3-0.5mg/100g. Phytosterols including beta-sitosterol and stigmasterol total approximately 50-100mg/100g. Vitamin K1 (phylloquinone) is present at approximately 8mcg/100g. Bioavailability note: carotenoids in palm oil are fat-soluble and demonstrate high bioavailability (~68% absorption efficiency) when consumed with meals; tocotrienol bioavailability is enhanced by dietary fat co-ingestion but is lower than tocopherols due to preferential hepatic metabolism; cold-pressing preserves significantly more bioactive compounds compared to refined, bleached, deodorized (RBD) palm oil.
Preparation & Dosage
Clinically studied doses for spray-dried encapsulated oil palm phenolics (OPP) range from 250-1500 mg/day, with 250 mg/day effective for blood pressure reduction and 1500 mg/day for antioxidant capacity in 60-day trials. No clinical data exists for cold-pressed palm oil itself. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Vitamin E, Coenzyme Q10, Alpha-lipoic acid, Grape seed extract, Green tea extract
Safety & Interactions
Cold-pressed palm oil is generally well tolerated at supplemental doses used in clinical trials (250–1500 mg/day OPP), with no serious adverse events reported in short-term studies. Due to its potential ACE-inhibitory activity, concurrent use with antihypertensive medications such as ACE inhibitors or ARBs may produce additive blood pressure-lowering effects warranting medical supervision. The high saturated fat content of palm oil (approximately 44% palmitic acid) raises theoretical concerns about LDL cholesterol elevation with chronic high-dose consumption, though cold-pressed phenolic-rich fractions differ from refined palm oil. Safety data in pregnant or breastfeeding women and pediatric populations is insufficient, and use in these groups should be approached cautiously.